CR11362A - Bisfosfonatos de alquilo de 2 a 5 atomos de carbono-imidazol - Google Patents
Bisfosfonatos de alquilo de 2 a 5 atomos de carbono-imidazolInfo
- Publication number
- CR11362A CR11362A CR11362A CR11362A CR11362A CR 11362 A CR11362 A CR 11362A CR 11362 A CR11362 A CR 11362A CR 11362 A CR11362 A CR 11362A CR 11362 A CR11362 A CR 11362A
- Authority
- CR
- Costa Rica
- Prior art keywords
- imidazol
- caromon
- bisphosphonates
- rent
- atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Se describen acidos [(imidazol-1-il)-1-hidroxi-1-fosfono-etil] -fosfonicos sustituidos por alquilo de 2 a 5 atomos de carbono, asi como metodos o procesos para su fabricacion, su uso en la fabricacion de formulaciones farmaceuticas, su uso en el tratamiento de enfermedades, metodos para utilizarlos en el tratamiento de enfermedades, formulaciones farmaceuticas que los abarcan, y/o los compuestos para utilizarse en el tratamiento de enfermedades.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07122016 | 2007-11-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR11362A true CR11362A (es) | 2010-06-14 |
Family
ID=39154111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR11362A CR11362A (es) | 2007-11-30 | 2010-04-09 | Bisfosfonatos de alquilo de 2 a 5 atomos de carbono-imidazol |
Country Status (24)
Country | Link |
---|---|
US (2) | US7977323B2 (es) |
EP (1) | EP2225252B1 (es) |
JP (1) | JP5244917B2 (es) |
KR (1) | KR20100092035A (es) |
CN (1) | CN101835787A (es) |
AR (1) | AR069437A1 (es) |
AU (1) | AU2008328797B2 (es) |
BR (1) | BRPI0819902A2 (es) |
CA (1) | CA2701516A1 (es) |
CL (1) | CL2008003545A1 (es) |
CO (1) | CO6280421A2 (es) |
CR (1) | CR11362A (es) |
EA (1) | EA201000860A1 (es) |
EC (1) | ECSP10010321A (es) |
ES (1) | ES2386851T3 (es) |
IL (1) | IL204657A0 (es) |
MA (1) | MA31895B1 (es) |
MX (1) | MX2010005786A (es) |
NZ (1) | NZ584219A (es) |
PE (1) | PE20091038A1 (es) |
TN (1) | TN2010000138A1 (es) |
TW (1) | TW200932248A (es) |
WO (1) | WO2009068567A1 (es) |
ZA (1) | ZA201001992B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2273980A2 (en) * | 2008-04-04 | 2011-01-19 | Novartis AG | Pharmaceutical composition with bisphosphonate |
US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
ES2650665T3 (es) | 2009-07-31 | 2018-01-19 | Grünenthal GmbH | Método de cristalización y biodisponibilidad |
US9169279B2 (en) | 2009-07-31 | 2015-10-27 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
US9290526B2 (en) | 2010-05-28 | 2016-03-22 | The Royal Institution For The Advancement Of Learning/Mcgill University | Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof |
WO2011147038A1 (en) | 2010-05-28 | 2011-12-01 | The Royal Institution For The Advancement Of Learning/Mcgill University | Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof |
WO2012071517A2 (en) | 2010-11-24 | 2012-05-31 | Thar Pharmaceuticals, Inc. | Novel crystalline forms |
CN102659840B (zh) * | 2012-05-10 | 2013-08-14 | 苏州普瑞诺药物技术有限公司 | 咪唑双膦酸类化合物及其可药用盐及药物用途 |
WO2017208070A1 (en) | 2016-05-31 | 2017-12-07 | Grünenthal GmbH | Bisphosphonic acid and coformers with lysin, glycin, nicotinamide for treating psoriatic arthritis |
CN111225672B (zh) | 2017-10-16 | 2023-09-29 | 清华大学 | 甲羟戊酸通路抑制剂及其药物组合物 |
CN112980809B (zh) * | 2021-03-17 | 2023-04-11 | 云南中烟工业有限责任公司 | 一种烟草法尼基焦磷酸合酶基因及其应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2038692T4 (es) * | 1986-11-21 | 2012-02-10 | Novartis Ag | Procedimiento para la obtencion de acidos alcanodifosfonicos substituidos. |
JP3727332B2 (ja) * | 1991-02-26 | 2005-12-14 | ノーウィッチ、イートン、ファーマスーティカルズ、インコーポレーテッド | 骨粗鬆症の治療方法 |
GB9324143D0 (en) | 1993-11-24 | 1994-01-12 | Schering Agrochemicals Ltd | Triazole phosphonate pesticides |
GB0029018D0 (en) * | 2000-11-28 | 2001-01-10 | Strakan Group Plc | Dermatological formulations |
GB0029111D0 (en) * | 2000-11-29 | 2001-01-10 | Novartis Ag | Organic compounds |
WO2008128056A1 (en) | 2004-10-08 | 2008-10-23 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps |
EP1802641B8 (en) | 2004-10-08 | 2012-03-07 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases |
PE20081043A1 (es) | 2006-10-05 | 2008-09-17 | Novartis Ag | Composicion farmaceutica que comprende bifosfonatos |
WO2008121687A2 (en) | 2007-03-28 | 2008-10-09 | Array Biopharma Inc. | Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors |
-
2008
- 2008-11-26 NZ NZ584219A patent/NZ584219A/en not_active IP Right Cessation
- 2008-11-26 BR BRPI0819902-7A patent/BRPI0819902A2/pt not_active IP Right Cessation
- 2008-11-26 EA EA201000860A patent/EA201000860A1/ru unknown
- 2008-11-26 CN CN200880112351A patent/CN101835787A/zh active Pending
- 2008-11-26 AU AU2008328797A patent/AU2008328797B2/en not_active Ceased
- 2008-11-26 WO PCT/EP2008/066245 patent/WO2009068567A1/en active Application Filing
- 2008-11-26 MX MX2010005786A patent/MX2010005786A/es active IP Right Grant
- 2008-11-26 EP EP08854485A patent/EP2225252B1/en active Active
- 2008-11-26 KR KR1020107014395A patent/KR20100092035A/ko not_active Application Discontinuation
- 2008-11-26 JP JP2010535369A patent/JP5244917B2/ja active Active
- 2008-11-26 US US12/323,696 patent/US7977323B2/en not_active Expired - Fee Related
- 2008-11-26 CA CA2701516A patent/CA2701516A1/en not_active Abandoned
- 2008-11-26 ES ES08854485T patent/ES2386851T3/es active Active
- 2008-11-27 AR ARP080105163A patent/AR069437A1/es active IP Right Grant
- 2008-11-27 PE PE2008001990A patent/PE20091038A1/es not_active Application Discontinuation
- 2008-11-28 CL CL2008003545A patent/CL2008003545A1/es unknown
- 2008-11-28 TW TW097146484A patent/TW200932248A/zh unknown
-
2010
- 2010-03-19 ZA ZA2010/01992A patent/ZA201001992B/en unknown
- 2010-03-22 IL IL204657A patent/IL204657A0/en unknown
- 2010-03-26 TN TNP2010000138A patent/TN2010000138A1/fr unknown
- 2010-04-09 CR CR11362A patent/CR11362A/es unknown
- 2010-05-26 CO CO10063351A patent/CO6280421A2/es not_active Application Discontinuation
- 2010-05-31 MA MA32880A patent/MA31895B1/fr unknown
- 2010-06-30 EC EC2010010321A patent/ECSP10010321A/es unknown
-
2011
- 2011-05-26 US US13/116,671 patent/US20110224173A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN101835787A (zh) | 2010-09-15 |
EA201000860A1 (ru) | 2010-12-30 |
JP5244917B2 (ja) | 2013-07-24 |
CA2701516A1 (en) | 2009-06-04 |
US7977323B2 (en) | 2011-07-12 |
BRPI0819902A2 (pt) | 2015-05-19 |
ZA201001992B (en) | 2010-12-29 |
AR069437A1 (es) | 2010-01-20 |
WO2009068567A1 (en) | 2009-06-04 |
TN2010000138A1 (en) | 2011-09-26 |
CO6280421A2 (es) | 2011-05-20 |
AU2008328797B2 (en) | 2011-11-03 |
ES2386851T3 (es) | 2012-09-03 |
CL2008003545A1 (es) | 2009-06-05 |
MX2010005786A (es) | 2010-06-09 |
TW200932248A (en) | 2009-08-01 |
AU2008328797A1 (en) | 2009-06-04 |
US20090143337A1 (en) | 2009-06-04 |
JP2011504908A (ja) | 2011-02-17 |
EP2225252A1 (en) | 2010-09-08 |
EP2225252B1 (en) | 2012-06-27 |
ECSP10010321A (es) | 2010-08-31 |
IL204657A0 (en) | 2010-11-30 |
PE20091038A1 (es) | 2009-08-19 |
KR20100092035A (ko) | 2010-08-19 |
US20110224173A1 (en) | 2011-09-15 |
MA31895B1 (fr) | 2010-12-01 |
NZ584219A (en) | 2012-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR11362A (es) | Bisfosfonatos de alquilo de 2 a 5 atomos de carbono-imidazol | |
UY29004A1 (es) | Compuestos derivados sustituídos de ácidos, glicina y alanina; procedimiento para su preparación y uso. | |
CR20120264A (es) | Compuestos | |
AR063628A1 (es) | Compuestos de piridinona utiles para el tratamiento de cancer | |
ECSP088749A (es) | Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos | |
BRPI0512683A (pt) | compostos anti-virais | |
UY33817A (es) | ?nuevas oxindolpirimidinas bencílicas?. | |
CR20110326A (es) | Compuestos pirazina como inhibidores de fosfodiesterasa 10 | |
CO6630189A2 (es) | Compuestos heterocíclicos de nitrógeno útiles como inhibidores de pde10 | |
PA8841901A1 (es) | Compuestos orgánicos | |
MX2010003925A (es) | Composiciones que comprenden moduladores del receptor de fosfato de esfingosina-1 (s1p). | |
CO6331340A2 (es) | Pirrolo-pirimidinas y pirrolo piridinas | |
UY29079A1 (es) | Acidos fenoxiacéticos sustituidos, composiciones que los contienen, procedimientos de preparación y aplicaciones | |
CU20120013A7 (es) | Derivados de oxacina y su uso como inhibidores de bace para el tratamiento de trastornos neurológicos | |
CL2012001073A1 (es) | Compuestos derivados de pirido[4,3-d]pirimidin-5-ona, sus composiciones farmaceuticas y su uso como inhibidores de quinasa para tratar asma, epoc, colitis ulcerante, bronquitis, lupus, cancer de mamas, enfermedad de alzheimer, enfermedad de parkinson, osteoporosis, esclerosis multiple, diabetes, trastornos oculares, restenosis, enfermedades inflamatorias. | |
CO6450612A2 (es) | Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750 | |
CL2011001295A1 (es) | Compuestos derivados de 1h-pirazol-4-carboxamida; metodo de control o prevencion de una infestacion de plantas utiles por microorganismos fitopatogenos; composicion pesticida que comprende a dichos compuestos. | |
CL2011001967A1 (es) | Compuestos derivados de carboxamida-azaheterociclica sustituida, inhibidores de p70s6k, proceso de preparacion de estos; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades inflamatorias y cancer; kit farmaceutico. | |
CL2012002487A1 (es) | Compuestos derivados de imidazo[1,2-a]pirazina, inhibidores de pde10; composicion farmacéutica que los comprende; proceso para preparar la composicion farmaceutica; utiles para el tratamiento de enfermedades neurológicas, psiquiátricas o metabólicas tales como esquizofrenia, parkinson y diabetes, entre otras. | |
UY30282A1 (es) | Compuestos quimicos | |
UY29839A1 (es) | Ácidos fenoxiaceticos sustituidos, composiciones farmacéuticas conteniéndolos, procesos para su preparación y aplicaciones. | |
CO6321136A2 (es) | Derivados de indazol sustituido por axadiazol para uso como agonistas de esfingosina 1 fosfato (s1p) | |
UY29343A1 (es) | Pirazolopiridinas y sales de las mismas, una composición farmacéutica que comprende dichos compuestos, un método para prepararlos y su uso. | |
CO6361849A2 (es) | Derivados de n-cicloalquil-nbifenilmetil-carboxamida fungicidas | |
ECSP099490A (es) | Métodos de fabricación y uso de compuestos y composiciones |